These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9013388)

  • 1. Effect of interferon-alpha on DOI-induced wet-dog shakes in rats.
    Kugaya A; Kagaya A; Uchitomi Y; Yokota N; Yamawaki S
    J Neural Transm (Vienna); 1996; 103(8-9):947-55. PubMed ID: 9013388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acute lipopolysaccharide administration on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2 aminopropane-induced wet dog shake behavior in rats: comparison with body weight change and locomotor activity.
    Kouhata S; Kagaya A; Nakae S; Nakata Y; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):395-407. PubMed ID: 11294484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute and chronic administration of dehydroepiandrosterone on (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced wet dog shaking behavior in rats.
    Inagaki M; Kagaya A; Takebayashi M; Horiguchi J; Yamawaki S
    J Neural Transm (Vienna); 1999; 106(1):23-33. PubMed ID: 10195332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and regional haemodynamic effects of 1-(2,5-dimethoxy-4-iodo-phenyl)-2-aminopropane (DOI) and alpha-methyl-5-HT, in the anaesthetised rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Clin Exp Hypertens; 1994 Nov; 16(6):779-98. PubMed ID: 7858559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of DOI-mediated wet dog shakes by inhibitors of nitric oxide synthase.
    Xu X; Miller KJ
    Brain Res; 1998 Sep; 804(2):337-40. PubMed ID: 9757078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.
    Marek GJ
    Neuropharmacology; 2009 Jun; 56(8):1082-7. PubMed ID: 19324062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes.
    Gorzalka BB; Hill MN; Sun JC
    Eur J Pharmacol; 2005 May; 516(1):28-33. PubMed ID: 15913602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian rhythm in the responsiveness of central 5-HT2A receptor to DOI in rats.
    Nagayama H; Lu JQ
    Psychopharmacology (Berl); 1996 Sep; 127(2):113-6. PubMed ID: 8888376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual behavior and wet dog shakes in the male rat: regulation by corticosterone.
    Gorzalka BB; Hanson LA
    Behav Brain Res; 1998 Dec; 97(1-2):143-51. PubMed ID: 9867239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cessation of chronic nicotine administration enhances wet-dog shake responses to 5-HT2 receptor stimulation in rats.
    Suemaru K; Araki H; Kitamura Y; Yasuda K; Gomita Y
    Psychopharmacology (Berl); 2001 Dec; 159(1):38-41. PubMed ID: 11797067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test.
    Makino M; Kitano Y; Komiyama C; Hirohashi M; Takasuna K
    Br J Pharmacol; 2000 Jul; 130(6):1269-74. PubMed ID: 10903965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low responsiveness to agents evoking 5-HT2 receptor-mediated behaviors in Sardinian alcohol-preferring rats.
    Ciccocioppo R; Panocka I; Stefanini E; Gessa GL; Massi M
    Pharmacol Biochem Behav; 1995 May; 51(1):21-7. PubMed ID: 7542392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinic acid inhibits DOI-induced head shakes in mice.
    Kariyawasam SH; Handley SL
    J Psychopharmacol; 1999; 13(3):284-6. PubMed ID: 10512085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
    Dedeoğlu A; Fisher LA
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of central 5-HT2 receptors in mediating head bobs and body shakes in the rabbit.
    Dave KD; Quinn JL; Harvey JA; Aloyo VJ
    Pharmacol Biochem Behav; 2004 Mar; 77(3):623-9. PubMed ID: 15006475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of corticosterone on serotonergic stereotypy and sexual behavior in the female rat.
    Hanson LA; Gorzalka BB
    Behav Brain Res; 1999 Oct; 104(1-2):27-35. PubMed ID: 11125740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
    Rittenhouse PA; Bakkum EA; Van de Kar LD
    J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.